Cognis is a supplier of specialty chemicals and nutritional ingredients, with a particular focus on the areas of wellness and sustainability to food, nutrition and healthcare markets and the cosmetics, detergents and cleaners industries. Its main business units include Oleochemicals, Care Chemicals, Nutrition and Health and Functional Products.
Expectations for its strategic business units include growth of care performance speciality products and the conjugated linoleic acid (CLA) business. Functional Products aims to benefit from operational improvements in North America and to generate sales out of new local capacity in Asia.
Oleochemicals’ growth plans are based on the benefits of initiatives at North American operations, increased sales quantities of fatty acids and an improvement in the oilfield chemicals business.
On 10 December 2010, BASF completed its €3.1bn ($4.1bn) acquisition of Cognis. For more on this please see BASF completes €3.1bn acquisition of Cognis on ICIS news.
In 2009, Cognis had sales of around Euro2.6bn and employs about 5,572 people with headquarters in Monheim, Germany.
Chief executive officer: Michael Heinz
Chief financial officer: Marco Panichi
Member of supervisory board: Klaus Edelmann
Chief administration officer and executive VP: Helmut Heymann
Executive VP (functional products): Paul Allen
Executive VP (nutrition and health): Stephane Baseden
Executive VP (care chemicals): Richard Ridinger
(Updated December 2010)
Cognis Rheinpromenade Alte Freiheit 1D-40789 MonheimGermany
Tel: +49 2173 4995 222Fax: +49 211 2006 10222 Email (corporate communications): email@example.com
Cognis is a supplier of specialty chemicals and nutritional ingredients, with a particular focus on the areas of wellness and sustainability to food, nutrition and healthcare markets and the cosmetics, detergents and cleaners industries. The Cognis group was established in August 1999 as a carve-out of the chemical products business of Henkel. On 30 November 2001, Cognis became a wholly independent enterprise. The investor group, Permira Funds, GS Capital Partners and Schroder Ventures Life Sciences took over Cognis from Henkel.
More about Cognis Structure
Cognis will focus on its three core business areas and continue to optimise its operations and processes to what it states as “equipping itself for the market challenges that lie ahead”. One example of this has been establishing a company-wide cost optimisation programme. (Edited from annual report). ICIS also provides you with key financial data listed in table form.
More about Cognis Strategy & Financial Highlights
Get news on Cognis plus the latest chemical news, information, data, market movements and analysis
in one place with ICIS news
Find details on other chemical companies and suppliers with
ICIS offers a range of FREE e-newsletters to ensure that you don't miss out on the latest development and key market intelligence in your industry. If you want the latest news sent to your inbox, sign up for ICIS e-newsletters today.
Find out more about current and planned chemical plants and projects by subscribing to our comprehensive database
INSIGHT: US chemicals sector welcomes TSCA reform bill
“We now have an historic legislative opportunity that can be embraced by both sides of the aisle.”
VIDEO - ICIS Americas Lunchtime Bulletin 23 May 2013